BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home
»
Authors
»
Randy Osborne
Articles by Randy Osborne
Patent Rumbles Aside, RNAi War To Be Waged In Clinic'
Feb. 6, 2006
By
Randy Osborne
Valera IPO Garners $33.75M For Work With Drug Implants
Feb. 3, 2006
By
Randy Osborne
Alnylam Stock Sale Raising $66.3M To Boost RNAi Bid
Feb. 2, 2006
By
Randy Osborne
Nuvelo Follows Bayer Deal With $104M Public Offering
Feb. 1, 2006
By
Randy Osborne
Cangene's Acute HBV Drug Wins Marketing Nod For U.S.
Feb. 1, 2006
By
Randy Osborne
CombinatoRx's Osteo Drug Proves Beneficial In Phase II
Jan. 31, 2006
By
Randy Osborne
SuperGen To Buy Montigen In Deal Worth Up To $30M
Jan. 30, 2006
By
Randy Osborne
Lilly ICOS Faltering in BPH Race; Threshold Moving On
Jan. 30, 2006
By
Randy Osborne
Alexion's Soliris Phase III Outstanding' Against PNH
Jan. 27, 2006
By
Randy Osborne
GeoVax Merger Gains $13M To Help HIV Vaccine Effort
Jan. 26, 2006
By
Randy Osborne
Previous
1
2
…
367
368
369
370
371
372
373
374
375
…
472
473
Next